Infection after transrectal ultrasonography-guided prostate biopsy: Increased relative risks after recent international Travel or Antibiotic Use

BJU International

Volumn 109, Issue 12, 2012, Pages 1785-1786

  Loeb, Stacy ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN;

AGE; BACTERIUM CULTURE; COMORBIDITY; DRUG USE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; NONHUMAN; NOTE; PRIORITY JOURNAL; PROSTATE BIOPSY; RACE; TRANSRECTAL ULTRASONOGRAPHY GUIDED PROSTATE BIOPSY; TRAVEL;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI INFECTIONS; HUMANS; MALE; PROSTATE; SEPSIS; TRAVEL;

EID: 84861571332     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10724.x     Document Type: Note

References (3)

1. Nam RK, Saskin R, Lee Y, et al,. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010; 183: 963-8
2. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM,. Complications Following Prostate Biopsy: Data from SEER-Medicare. J Urol 2011; 186: 1830-4
3. Zhanel GG, Hisanaga TL, Laing NM, et al,. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2005; 26: 380-8